Topic prioritisation

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Decision date

Decision date

Prioritisation programme

Prioritisation programme

Decision

Decision

Showing 1 to 10 of 21

TitlePrioritisation programmeDecisionDecision date
Ponatinib for treating recurrent or refractory chronic myeloid leukaemia in people 1 to 17 years when another tyrosine kinase inhibitor is unsuitable [TSID12041]Medicines evaluationNot selected
Ferric citrate for managing iron and serum phosphorus levels in anaemia associated with chronic kidney disease [TSID12221]None selectedNot selected
Zanubrutinib for Chronic lymphocytic leukaemia (CLL) or Follicular lymphoma or Marginal zone lymphoma (MZL) or Waldenstrom's macroglobulinaemia [ID12199]None selectedNot selected
Nifedipine - Lidocaine for Chronic Anal Fissure [TSID 12093]None selectedNot selected
Veverimer for treating metabolic acidosis in chronic kidney disease [ID3832]None selectedAwaiting decision
Avatrombopag for treating primary chronic immune thrombocytopenia in people 1 to 17 years [TSID12109]None selectedNot selected
Linaclotide acetate for treating Chronic idiopathic constipation [TSID12005]None selectedNot selected
Human normal immunoglobulin for preventing infection in chronic lymphocytic leukaemia [TSID12043]None selectedNot selected
Human normal immunoglobulin for preventing infection in chronic lymphocytic leukaemia [TSID12043]None selectedNot selected
Mepolizumab for treating chronic obstructive pulmonary disease with eosinophil-associated exacerbations TSID12019None selectedNot selected

Results per page

  1. 10
  2. 25
  3. 50
  4. All